Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts

Transplantation

Volumn 86, Issue 8, 2008, Pages 1125-1134

  Zhang, Wei ^a   Liang, Siyuan ^a   Wu, Juan ^a   Horuzsko, Anatolij ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Allograft survival; HLA G; Immunosuppression; Inhibitory receptor; Mice; Myeloid derived suppressor cells

Indexed keywords

HLA G ANTIGEN; IMMUNOGLOBULIN RECEPTOR; INHIBITORY RECEPTOR IMMUNOGLOBULIN LIKE TRANSCRIPT 2; UNCLASSIFIED DRUG; CD11B ANTIGEN; CHEMOKINE RECEPTOR; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; LEUKOCYTE ANTIGEN; LIGAND; LILRB1 PROTEIN, HUMAN;

ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL POPULATION; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIGAND BINDING; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN ALLOGRAFT; SURVIVAL TIME; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; GENETIC TRANSCRIPTION; GENETICS; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SKIN TRANSPLANTATION; T LYMPHOCYTE; TIME; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; ANTIGENS, CD11B; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS; PHENOTYPE; RECEPTORS, CHEMOKINE; RECEPTORS, IMMUNOLOGIC; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 55949116639     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318186fccd     Document Type: Article

References (38)

1. Carosella ED, Moreau P, Le Maoult J, et al. HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81: 199.
2. Rouas-Freiss N, LeMaoult J, Moreau P, et al. HLA-G in transplantation: A relevant molecule for inhibition of graft rejection? Am J Transplant 2003; 3: 11.
3. Hunt JS, Petroff MG, McIntire RH, et al. HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19: 681.
4. Carosella ED, Moreau P, Lemaoult J, et al. HLA-G: From biology to clinical benefits. Trends Immunol 2008; 29: 125.
5. Hunt JS, Jadhav L, Chu W, et al. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000; 183: 682.
6. Le Bouteiller P, Legrand-Abravanel F, Solier C. Soluble HLA-G1 at the materno-foetal interface. A review. Placenta 2003; 24: S10.
7. LeMaoult J, Krawice-Radanne I, Dausset J, et al. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 2004; 101: 7064.
8. Rajagopalan S, Long EO. Viral evasion of NK-cell activation. Trends Immunol 2005; 26: 403.
9. Ristich V, Liang S, Zhang W, et al. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005; 35: 1133.
10. LeMaoult J, Zafaranloo K, Le Danff C, et al. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005; 19: 662.
11. Liang S, Zhang W, Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol 2006; 36: 2457.
12. Liang S, Ristich V, Arase H, et al. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci USA 2008; 105: 8357.
13. Feger U, Tolosa E, Huang YH, et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 2007; 110:568.
14. Rouas-Freiss N, Naji A, Durrbach A, et al. Tolerogenic functions of human leukocyte antigen G: From pregnancy to organ and cell transplantation. Transplantation 2007; 84(1 Suppl): S21.
15. Gallina G, Dolcetti L, Serafini P, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006; 116: 2777.
16. Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004; 6: 409.
17. KusmartsevS, Nagaraj S, Gabrilovich DI. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J Immunol 2005; 175:4583.
18. Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2006; 16: 53.
19. Nagaraj S, Gupta K, Pisarev V, et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007; 13:828.
20. Liang S, Baibakov B, Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 2002; 32: 2418.
21. Ochoa JB, Bernard AC, O'Brien WE, et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 2001; 233: 393.
22. Tsuei BJ, Bernard AC, Shane MD, et al. Surgery induces human mononuclear cell arginase I expression. J Trauma 2001; 51: 497.
23. Makarenkova VP, Bansal V, MattaBM, et al. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006; 176: 2085.
24. Broxmeyer HE, Cooper S, Hangoc G, et al. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins. Exp Hematol 2006; 34: 1078.
25. Bunt SK, Sinha P, Clements VK, et al. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol 2006; 176: 284.
26. Zheng XX, Sanchez-Fueyo A, Domenig C, et al. The balance of deletion and regulation in allograft tolerance. Immunol Rev 2003; 196: 75.
27. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
28. Wells AD, Li XC, Strom TB, et al. The role of peripheral T-cell deletion in transplantation tolerance. Philos Trans R Soc Lond B Biol Sci 2001; 356: 617.
29. Wood KJ, Jones ND, Bushell AR, et al. Alloantigen-induced specific immunological unresponsiveness. Philos Trans R Soc Lond B Biol Sci 2001; 356: 665.
30. Waldmann H, Cobbold S. Regulating the immune response to transplants. A role for CD4+ regulatory cells? Immunity 2001; 14: 399.
31. GracaL, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
32. Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3: 189.
33. Dietrich J, Cella M, Colonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol 2001; 166: 2514.
34. Sayos J, Martinez-Barriocanal A, Kitzig F, et al. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem Biophys Res Commun 2004; 324: 640.
35. Lowell CA. Src-family kinases: Rheostats of immune cell signaling. Mol Immunol 2004; 41: 631.
36. Karur VG, Lowell CA, Besmer P, et al. Lyn kinase promotes erythro-blast expansion and late-stage development. Blood 2006; 108: 1524.
37. Bronte V, Serafini P, Mazzoni A, et al. L-arginine metabolism in myeloid cells controls T lymphocyte functions. Trends Immunol 2003; 24: 302.
38. Frey AB. Myeloid suppressor cells regulate the adaptive immune response to cancer. J Clin Invest 2006; 116: 2587.